Ardent Health Partners, LLC (NYSE:ARDT) Shares Acquired by Formula Growth Ltd.

Formula Growth Ltd. lifted its stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) by 46.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 166,000 shares of the company's stock after acquiring an additional 53,000 shares during the quarter. Formula Growth Ltd. owned 0.12% of Ardent Health Partners worth $2,835,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the stock. US Bancorp DE acquired a new position in Ardent Health Partners during the fourth quarter worth $31,000. R Squared Ltd purchased a new stake in shares of Ardent Health Partners in the 4th quarter valued at $37,000. BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the 3rd quarter worth about $42,000. New York State Common Retirement Fund purchased a new position in Ardent Health Partners during the 4th quarter valued at about $48,000. Finally, JPMorgan Chase & Co. acquired a new position in Ardent Health Partners in the 3rd quarter valued at about $154,000.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Stephens reissued an "overweight" rating and set a $22.00 price target on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Morgan Stanley reduced their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating on the stock in a report on Tuesday, January 21st. Truist Financial dropped their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Mizuho reduced their price objective on Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Finally, Guggenheim assumed coverage on Ardent Health Partners in a research note on Wednesday, April 9th. They set a "buy" rating and a $16.00 target price for the company. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $20.58.

Ardent Health Partners Stock Up 2.4 %

ARDT stock traded up $0.29 during trading on Thursday, hitting $12.59. 52,766 shares of the company's stock were exchanged, compared to its average volume of 445,226. The business has a 50-day moving average price of $13.44 and a two-hundred day moving average price of $15.44. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a 52-week low of $11.31 and a 52-week high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.31. The company had revenue of $1.61 billion for the quarter, compared to analysts' expectations of $1.48 billion. As a group, equities research analysts expect that Ardent Health Partners, LLC will post 1.23 EPS for the current fiscal year.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.